PHP
THRD

Parkman Healthcare Partners’s Third Harmonic Bio THRD Stock Holding History

Parkman Healthcare Partners’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-86,707
Closed -$892K – 105
2024
Q4 		$892K Sell
86,707
-151,113
-64% -$1.88M 0.12% 84
2024
Q3 		$3.22M Buy
237,820
+104,495
+78% +$1.29M 0.41% 64
2024
Q2 		$1.73M Buy
133,325
+93,325
+233% +$1.15M 0.23% 76
2024
Q1 		$378K Buy
+40,000
New +$389K 0.05% 98

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Parkman Healthcare Partners's THRD Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 86,707 shares — an estimated $892K sold.

Parkman Healthcare Partners first reported a position in THRD in Q1 2024 and held it in 4 quarters. The position peaked at $3.22M in Q3 2024. 100 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 86,707 Third Harmonic Bio shares in Q1 2025, an estimated $892K.
  • Parkman Healthcare Partners first reported a position in Third Harmonic Bio in Q1 2024 and held it in 4 quarters.
  • Parkman Healthcare Partners's Third Harmonic Bio position peaked at $3.22M in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.